The EMA has approved dupilumab for the treatment of esophagitis in children from one year old
For citations:
The EMA has approved dupilumab for the treatment of esophagitis in children from one year old. Pediatric pharmacology. 2024;21(6):569. (In Russ.)
Views:
126
Email this article 